Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The selenium field has grown dramatically in the years since the first edition of Selenium: Its Molecular Biology and Role in Human Health was published in 2001. All aspects of selenium biology have advanced with many new approaches and insights into the biochemical, molecular, genetic, and health areas of this intriguing element. The third edition of Selenium: Its Molecular Biology and Role in Human Health brings readers up to date and informs them of the present knowledge of the molecular biology of selenium, its incorporation into proteins as selenocysteine, and the role that this element and selenium-containing proteins (selenoproteins) play in health and development. The current edition will be an important resource for scientists and investigators in the selenium field, students, and physicians who wish to learn more about this fascinating micronutrient.

Selenium -- Health aspects. --- Selenium -- Physiological effect. --- Selenium in human nutrition. --- Selenium --- Selenium in human nutrition --- Proteins --- Chalcogens --- Minerals --- Cysteine --- Protective Agents --- Organoselenium Compounds --- Molecular Mechanisms of Pharmacological Action --- Physiological Effects of Drugs --- Specialty Uses of Chemicals --- Amino Acids, Peptides, and Proteins --- Organic Chemicals --- Pharmacologic Actions --- Elements --- Amino Acids, Sulfur --- Inorganic Chemicals --- Chemicals and Drugs --- Chemical Actions and Uses --- Sulfur Compounds --- Amino Acids --- Antioxidants --- Selenocysteine --- Selenoproteins --- Chemistry --- Human Anatomy & Physiology --- Biology --- Health & Biological Sciences --- Physical Sciences & Mathematics --- Biochemistry --- Animal Biochemistry --- Biology - General --- Health aspects --- Physiological effect --- Health aspects. --- Physiological effect. --- Life sciences. --- Immunology. --- Nutrition. --- Biochemistry. --- Life Sciences. --- Biochemistry, general. --- Nutrition --- Native element minerals --- Nonmetals

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Biomarkers are of critical medical importance for oncologists, allowing them to predict and detect disease and to determine the best course of action for cancer patient care. Prognostic markers are used to evaluate a patient’s outcome and cancer recurrence probability after initial interventions such as surgery or drug treatments and, hence, to select follow-up and further treatment strategies. On the other hand, predictive markers are increasingly being used to evaluate the probability of benefit from clinical intervention(s), driving personalized medicine. Evolving technologies and the increasing availability of “multiomics” data are leading to the selection of numerous potential biomarkers, based on DNA, RNA, miRNA, protein, and metabolic alterations within cancer cells or tumor microenvironment, that may be combined with clinical and pathological data to greatly improve the prediction of both cancer progression and therapeutic treatment responses. However, in recent years, few biomarkers have progressed from discovery to become validated tools to be used in clinical practice. This Special Issue comprises eight review articles and five original studies on novel potential prognostic and predictive markers for different cancer types.

Medicine --- MSI2 --- OSCC --- oral cancer --- musashi 2 --- prognosis --- N-cadherin --- EMT --- breast cancer --- new metastasis --- eribulin --- blood --- biomarker --- bladder cancer --- immune checkpoint inhibitor --- CD8+ T effector cells --- microRNA --- biomarkers --- head and neck cancer --- laryngeal cancer --- prediction --- metastasis --- lifestyle habit --- chemo-/radio resistance --- therapeutic target --- AKT --- AR --- castration-resistant prostate cancer (CRPC) --- MAPK --- mTOR --- PI3K --- prostate cancer --- therapeutic resistance --- WNT --- miRNA --- melanoma --- melanoma resistance to MAPK/MEK inhibitors --- resistance to immune checkpoint inhibitors --- TNBC --- BRCA1/2 --- HRR --- PDL1 --- TILs --- PI3KCA --- PTEN --- CTCs --- CSC --- pancreatic cancer --- K-RAS oncogene --- oncogene dependency --- targeted therapies --- genomic mutations --- transcriptomics --- metabolomics --- selenoproteins --- cancer --- HUB nodes --- major histocompatibility complex (MHC) --- human leukocyte antigen (HLA) --- antigen processing machinery (APM) molecules --- carcinogenesis --- tumor predisposition --- cancer immunotherapy --- pheochromocytoma --- paraganglioma --- head and neck neoplasms --- head and neck tumors --- genetic syndromes --- mutations --- hyperglycemia --- cardioncology --- nivolumab --- cytokines --- cardiotoxicity --- acetyltransferase --- cancer prognosis --- NAA10 --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Biomarkers are of critical medical importance for oncologists, allowing them to predict and detect disease and to determine the best course of action for cancer patient care. Prognostic markers are used to evaluate a patient’s outcome and cancer recurrence probability after initial interventions such as surgery or drug treatments and, hence, to select follow-up and further treatment strategies. On the other hand, predictive markers are increasingly being used to evaluate the probability of benefit from clinical intervention(s), driving personalized medicine. Evolving technologies and the increasing availability of “multiomics” data are leading to the selection of numerous potential biomarkers, based on DNA, RNA, miRNA, protein, and metabolic alterations within cancer cells or tumor microenvironment, that may be combined with clinical and pathological data to greatly improve the prediction of both cancer progression and therapeutic treatment responses. However, in recent years, few biomarkers have progressed from discovery to become validated tools to be used in clinical practice. This Special Issue comprises eight review articles and five original studies on novel potential prognostic and predictive markers for different cancer types.

MSI2 --- OSCC --- oral cancer --- musashi 2 --- prognosis --- N-cadherin --- EMT --- breast cancer --- new metastasis --- eribulin --- blood --- biomarker --- bladder cancer --- immune checkpoint inhibitor --- CD8+ T effector cells --- microRNA --- biomarkers --- head and neck cancer --- laryngeal cancer --- prediction --- metastasis --- lifestyle habit --- chemo-/radio resistance --- therapeutic target --- AKT --- AR --- castration-resistant prostate cancer (CRPC) --- MAPK --- mTOR --- PI3K --- prostate cancer --- therapeutic resistance --- WNT --- miRNA --- melanoma --- melanoma resistance to MAPK/MEK inhibitors --- resistance to immune checkpoint inhibitors --- TNBC --- BRCA1/2 --- HRR --- PDL1 --- TILs --- PI3KCA --- PTEN --- CTCs --- CSC --- pancreatic cancer --- K-RAS oncogene --- oncogene dependency --- targeted therapies --- genomic mutations --- transcriptomics --- metabolomics --- selenoproteins --- cancer --- HUB nodes --- major histocompatibility complex (MHC) --- human leukocyte antigen (HLA) --- antigen processing machinery (APM) molecules --- carcinogenesis --- tumor predisposition --- cancer immunotherapy --- pheochromocytoma --- paraganglioma --- head and neck neoplasms --- head and neck tumors --- genetic syndromes --- mutations --- hyperglycemia --- cardioncology --- nivolumab --- cytokines --- cardiotoxicity --- acetyltransferase --- cancer prognosis --- NAA10 --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The trace mineral selenium is still regarded as one of the most interesting and health-beneficial elements. In addition to the Editorial containing a dedication to Dr. Leopold Flohé, this Special Issue contains 13 research articles and 8 reviews, with over 120 different contributors covering many of the most important subjects concerning the study of selenium. The articles address both selenium as well as selenoproteins and their molecular roles, providing important considerations regarding this trace element’s impact on human and animal health and disease.

Research & information: general --- Biology, life sciences --- selenoproteome --- selenoprotein hierarchy --- nonradioactive isotopes --- SEC-ICP MS --- glutathione peroxidase --- thioredoxin reductase --- SECIS --- translation regulation --- autoimmune thyroid disease --- diabetes mellitus --- Graves’ disease --- Hashimoto thyroiditis --- infection --- inflammation --- long-COVID --- rheumatoid arthritis --- selenoprotein P --- sepsis --- selenoprotein W --- thioredoxin --- 14-3-3 --- Akt --- cell death --- Selenof --- selenium --- selenoprotein --- colon cancer --- barrier integrity --- cardiovascular --- heart --- selenoproteins --- Keshan’s Disease --- bacteria --- selenite --- selenium delivery system --- Trsp --- hypothalamus --- Agrp neuron --- sex differences --- diet-induced obesity --- leptin resistance --- macrophage --- differentiation --- redox signaling --- NRF2 --- NF-κB --- lipid mediators --- seleocysteine --- autoimmunity --- lymphocyte --- cadmium cytotoxicity --- cancer therapy --- cisplatin --- ICP-MS --- nonsynonymous mutation --- selenium homeostasis --- ZIP8 --- Trit1 --- isopentenylation --- tRNA[Ser]Sec --- selenocysteine --- genetic variance --- human disease --- selenophosphate synthetase --- endothelial cell --- reactive oxygen species --- cell growth --- angiogenesis --- SEPHS1 --- early embryogenesis --- embryonic lethality --- prostate --- cancer --- tumor suppressor --- selenoprotein deficiency --- SECISBP2 --- Sec-tRNA[Ser]Sec --- SEPSECS --- antioxidative defense --- autoantibody --- Hashimoto’s thyroiditis --- trace element --- recoding --- SECIS-binding protein --- translation termination --- nonsense-mediated decay --- ribosome rescue --- health --- mouse models --- selenocysteine (Sec) --- virus --- viral --- antioxidant --- HIV --- HCV --- HBV --- coxsackie virus --- influenza --- n/a --- HIV-1 --- viral infection --- SELENOS --- SELENOO --- primary T cells --- Jurkat --- SupT1 --- translational control --- Graves' disease --- Keshan's Disease --- Hashimoto's thyroiditis

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The trace mineral selenium is still regarded as one of the most interesting and health-beneficial elements. In addition to the Editorial containing a dedication to Dr. Leopold Flohé, this Special Issue contains 13 research articles and 8 reviews, with over 120 different contributors covering many of the most important subjects concerning the study of selenium. The articles address both selenium as well as selenoproteins and their molecular roles, providing important considerations regarding this trace element’s impact on human and animal health and disease.

selenoproteome --- selenoprotein hierarchy --- nonradioactive isotopes --- SEC-ICP MS --- glutathione peroxidase --- thioredoxin reductase --- SECIS --- translation regulation --- autoimmune thyroid disease --- diabetes mellitus --- Graves’ disease --- Hashimoto thyroiditis --- infection --- inflammation --- long-COVID --- rheumatoid arthritis --- selenoprotein P --- sepsis --- selenoprotein W --- thioredoxin --- 14-3-3 --- Akt --- cell death --- Selenof --- selenium --- selenoprotein --- colon cancer --- barrier integrity --- cardiovascular --- heart --- selenoproteins --- Keshan’s Disease --- bacteria --- selenite --- selenium delivery system --- Trsp --- hypothalamus --- Agrp neuron --- sex differences --- diet-induced obesity --- leptin resistance --- macrophage --- differentiation --- redox signaling --- NRF2 --- NF-κB --- lipid mediators --- seleocysteine --- autoimmunity --- lymphocyte --- cadmium cytotoxicity --- cancer therapy --- cisplatin --- ICP-MS --- nonsynonymous mutation --- selenium homeostasis --- ZIP8 --- Trit1 --- isopentenylation --- tRNA[Ser]Sec --- selenocysteine --- genetic variance --- human disease --- selenophosphate synthetase --- endothelial cell --- reactive oxygen species --- cell growth --- angiogenesis --- SEPHS1 --- early embryogenesis --- embryonic lethality --- prostate --- cancer --- tumor suppressor --- selenoprotein deficiency --- SECISBP2 --- Sec-tRNA[Ser]Sec --- SEPSECS --- antioxidative defense --- autoantibody --- Hashimoto’s thyroiditis --- trace element --- recoding --- SECIS-binding protein --- translation termination --- nonsense-mediated decay --- ribosome rescue --- health --- mouse models --- selenocysteine (Sec) --- virus --- viral --- antioxidant --- HIV --- HCV --- HBV --- coxsackie virus --- influenza --- n/a --- HIV-1 --- viral infection --- SELENOS --- SELENOO --- primary T cells --- Jurkat --- SupT1 --- translational control --- Graves' disease --- Keshan's Disease --- Hashimoto's thyroiditis